Peter Fedichev

CEO, GERO.ai

A scientist and entrepreneur with over 20 years of experience in academic research and the biotech industry, he currently serves as CEO of Gero.ai — a biotechnology company leveraging AI to understand and combat aging and chronic diseases. Under his leadership, Gero.ai has developed proprietary physics-based machine learning models, known as Large Health Models (LHMs), which analyze human health data to distinguish aging effects from disease processes. This approach enables more precise drug discovery aimed at extending both healthspan and lifespan.